Rethinking the rabies vaccine
A new high-resolution structure of the rabies virus glycoprotein reveals potential vaccine targets. …
Head-to-head comparison of four COVID-19 vaccines
Study provides the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. …
Potential new targets in immune cells for treating Parkinson’s disease
A genetic signature has been identified in memory T cells of Parkinson’s disease patients, suggesting potential therapeutic targets to stop autoimmune attacks on brain cells. …
Promising antibody cocktail takes on Ebola virus—and its deadly cousin
A cocktail of two monoclonal antibodies completely protects nonhuman primates from Ebola virus and Sudan virus infections. …
Current COVID-19 vaccines teach T cells to fight Omicron
Four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2, including the Delta and Omicron variants. …
Partial bone marrow transplant ‘rescues’ mice with cystic fibrosis
Scientists have found they can dramatically improve survival of mice with cystic fibrosis through a partial bone marrow transplant. …
Macrophages in the artery wall ‘smell’ their surroundings
Macrophages can sniff out octanal in blood, triggering dangerous inflammation and atherosclerosis. …
COVID-19 severity: How genetic variations leave immune cells at a disadvantage
New findings show how genetic variations linked to severe COVID-19 affect our immune cells. …
Moderna COVID-19 vaccine spurs lasting immune response
A new study helps answer the question: how long does immunity against COVID-19 last in vaccinated people? …
Vitamin C is a key ingredient for immune cell function
Whole-genome analysis reveals essential roles of vitamin C and TET enzymes in generating stable regulatory T cells (Tregs). …
End of content
End of content